CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,739,100
- in 9 filings, $213K under 10b5-1 plans
Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Hidalgo Medina Manuel Director | Sale | −1,000 | $107.10 | $107K | 1,889 |
| 2026-05-20 | Hidalgo Medina Manuel Director | Sale | −250 | $107.07 | $27K | 1,639 |
| 2026-05-20 | Hidalgo Medina Manuel Director | Option exercise · Stock Option (Right to Buy) | −1,000 | 13,029 | ||
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −200 | $100.95 | $20K | 2,096,304 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −900 | $102.57 | $92K | 2,095,404 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −1,366 | $103.82 | $142K | 2,094,038 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −11,919 | $105.01 | $1.3M | 2,082,119 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −1,200 | $105.88 | $127K | 2,080,919 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −21,171 | $106.99 | $2.3M | 2,059,748 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −33,069 | $108.11 | $3.6M | 2,026,679 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −9,852 | $108.97 | $1.1M | 2,016,827 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −28,908 | $110.10 | $3.2M | 1,987,919 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −37,163 | $111.14 | $4.1M | 1,950,756 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −37,900 | $112.02 | $4.2M | 1,912,856 |
| 2026-05-20 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −26,352 | $112.76 | $3.0M | 1,886,504 |
| 2026-05-20 | Saia John G. Chief Legal Officer | Sale 10b5-1 | −5,632 | $105.34 | $593K | 60,318 |
| 2026-05-20 | Saia John G. Chief Legal Officer | Sale 10b5-1 | −7,187 | $106.71 | $767K | 53,131 |
| 2026-05-20 | Saia John G. Chief Legal Officer | Sale 10b5-1 | −7,181 | $107.23 | $770K | 45,950 |
| 2026-05-20 | CLARK IAN T Director | Sale | −6,876 | $106.90 | $735K | 2,975 |
| 2026-05-18 | Tariq Musa Director | Sale 10b5-1 | −116 | $95.96 | $11K | 8,662 |
Page 16 of 22 · 421 trades